Stockreport

Tarsus Pharmaceuticals Full Year 2023 Earnings: Beats Expectations [Yahoo! Finance]

Tarsus Pharmaceuticals, Inc.  (TARS) 
PDF Net loss: US$135.9m (loss widened by 119% from FY 2022). US$4.63 loss per share (further deteriorated from US$2.52 loss in FY 2022). All figures shown in the chart [Read more]